← Leaderboards
Adam S Helms
University Of Michigan At Ann Arbor
$3,584,289
Attributed
$3,584,289
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,584,289 · 5
By mechanism
R01$2,132,393 · 2
K08$817,598 · 1
R56$478,298 · 1
R03$156,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Alison Schroer Vander Roest$1,179,175
- Sharlene M Day$8,991,177
- Andrea Dooley Thompson$759,288
- Anthony Rosenzweig$35,493,023
- Michael Robert Mathis$3,565,541
Others in their field
Top investigators on “Cardiac”
- Judith S Hochman · New York University School Of Medicine$110,228,771
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$69,868,084
- Rose A Gubitosi-Klug · Case Western Reserve University$61,225,818
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,141,827
- Joseph C Wu · Stanford University$53,027,789
- Pamela Susan Douglas · Duke University$51,506,531
Research focus
CardiacGeneticInduced Pluripotent Stem CellGenesCardiac MyocytesCellsPhenotypeMyocardiumProteinsLoss Of FunctionHeart FailureArrhythmiaHeartLeadMouse ModelCalciumFunctional DisorderAffectFutureIn VivoHypertrophic CardiomyopathyPathway InteractionsCrispr/Cas TechnologyMutation
Grant awards (11)
Cis regulatory variants of haploinsufficiency genes as cardiomyopathy modifiers$725,005
R01 · FY2025 · HL · contact PI
Stoichiometric, adhesion, and contractile deficits in desmoplakin cardiomyopathy$651,349
R01 · FY2025 · HL · contact PI
Cis regulatory variants of haploinsufficiency genes as cardiomyopathy modifiers$756,039
R01 · FY2024 · HL · contact PI
Development of a high throughput microtissue model for integrative analysis of contractile function and biomechanical stress in iPSC-derived cardiomyocytes$78,000
R03 · FY2022 · HL · contact PI
Dissection and Rescue of Mechanical and Transcriptional Defects in Desmoplakin Cardiomyopathy$478,298
R56 · FY2021 · HL · contact PI
Development of a high throughput microtissue model for integrative analysis of contractile function and biomechanical stress in iPSC-derived cardiomyocytes$78,000
R03 · FY2021 · HL · contact PI
Genome-Engineered Stem Cell Models to Determine Disease Mechanisms in MYBPC3 Hypertrophic Cardiomyopathy$163,620
K08 · FY2020 · HL · contact PI
Genome-Engineered Stem Cell Models to Determine Disease Mechanisms in MYBPC3 Hypertrophic Cardiomyopathy$163,620
K08 · FY2019 · HL · contact PI
Genome-Engineered Stem Cell Models to Determine Disease Mechanisms in MYBPC3 Hypertrophic Cardiomyopathy$163,620
K08 · FY2018 · HL · contact PI
Genome-Engineered Stem Cell Models to Determine Disease Mechanisms in MYBPC3 Hypertrophic Cardiomyopathy$163,325
K08 · FY2017 · HL · contact PI
Genome-Engineered Stem Cell Models to Determine Disease Mechanisms in MYBPC3 Hypertrophic Cardiomyopathy$163,413
K08 · FY2016 · HL · contact PI